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The toxicity of soluble metal compounds is often different from that of the parent metal.
Since no reliable data on acute toxicity, local effects, and mutagenicity of beryllium metal
have ever been generated, beryllium metal powder was tested according to the respective
Organisation for Economical Co-Operation and Development (OECD) guidelines. Acute
oral toxicity of beryllium metal was investigated in rats and local effects on skin and eye
in rabbits. Skin-sensitizing properties were investigated in guinea pigs (maximization
method). Basic knowledge about systemic bioavailability is important for the design of geno-
toxicity tests on poorly soluble substances. Therefore, it was necessary to experimentally
compare the capacities of beryllium chloride and beryllium metal to form ions under simu-
lated human lung conditions. Solubility of beryllium metal in artiﬁcial lung ﬂuid was low,
while solubility in artiﬁcial lysosomal ﬂuid was moderate. Beryllium chloride dissolution
kinetics were largely different, and thus, metal extracts were used in the invitro genotoxicity
tests. Genotoxicity was investigated invitro in a bacterial reverse mutagenicity assay, a mam-
malian cell gene mutation assay, a mammalian cell chromosome aberration assay, and an un-
scheduled DNA synthesis (UDS) assay. In addition, cell transformation was tested in a Syrian
hamsterembryocell assay, and potential inhibition of DNA repairwas tested by modiﬁcation
of the UDS assay. Beryllium metal was found not to be mutagenic or clastogenic based on the
experimental in vitro results. Furthermore, treatment with beryllium metal extracts did not
induce DNA repair synthesis, indicative of no DNA-damaging potential of beryllium metal.
A cell-transforming potential and a tendency to inhibit DNA repair when the cell is severely
damaged by an external stimulus were observed. Beryllium metal was also found not to be
a skin or eye irritant, not to be a skin sensitizer, and not to have relevant acute oral toxic
properties.
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INTRODUCTION
Beryllium metal has physical properties that
make its use essential for very speciﬁc applications,
such as medical diagnostics, nuclear/fusion reactors,
and aerospace applications. Only very few articles
contain pure beryllium metal or high beryllium-
containing composite parts, while most of the beryl-
lium metal is used in copper alloys containing low
levels (typically  2%) of the substance. Alloys
containing beryllium are used in electronics, energy,
automotive, and aerospace applications because of
their high strength, elasticity, electrical and thermal
conductivity, high melting point, fatigue resistance,
and resistance to oxidation. Manufacturers, concerned
about the life cycles of their products, use beryllium
and beryllium-containing alloys to reduce weight,
mass, raw materials, and waste. The impact on fuel
consumption (reduction of aeronautic and aerospace
vehicle weights) and miniaturization of electrical
parts issigniﬁcantand cannotbeattainedbyany other
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30material without negative impacts on performance
technology and the environment. High-resolution
medical diagnostic X-rays are not possible without
the use of beryllium metal.
Thehazardsofberylliumweremostlyassessedand
classiﬁed in the past by grouping it together with
soluble beryllium compounds although intrinsic
physical and chemical properties as well as toxicity
ofsolublemetal saltsarenaturallydifferentfromthat
oftheparentmetal.Itisknownfromseveralexamples
in toxicology that oxidation state and charge can
heavily inﬂuence metals’ toxicity. For examples,
the health effects of hexavalent chromium are
clearly different from that of chromium metal; the
same is true for soluble nickel compounds and nickel
metal.
Since no reliable data on acute toxicity, local
effects, and mutagenicity of beryllium metal have
ever been generated, beryllium metal powder was
tested according to the respective Organisation
for Economical Co-Operation and Development
(OECD) guidelines for inclusion in the technical
dossier for beryllium metal as required by the
REACH Regulation (EC) No 1907/2006. In addi-
tion, it is of practical beneﬁt to test beryllium metal
since the insoluble forms of beryllium products com-
prise almost 100% of the commercial market while
commercial application of soluble beryllium salts
is extremely rare and conﬁned to laboratory uses.
Conducting invitro genotoxicity tests with soluble
metal salts is not considered adequate when the
dissolution kinetics between the salt and the metal
differs. It is recognized that the complex environ-
ment of the lung cannot be easily simulated in vitro;
however, it is critical to try to at least basically un-
derstand what exposes the cells in vivo before de-
signing in vitro experiments on poorly soluble
compounds. Consequently, as a basic approxima-
tion, an ionformation test wasconducted with the in-
tention to compare the dissolution behavior of
beryllium metal and beryllium chloride (as a repre-
sentative of soluble beryllium compounds) under
conditions simulating inhaled beryllium metal in
the human lung [non-abrasive shaking for up to 28
days in the dark under normal lung (pH 7.4) and
lysosomal (pH 4.5) conditions]. It is important to
note that when evaluating solubility of metals, the
suspended particulate matter must be removed by
centrifugation (Midander et al., 2006). The results
obtained from the ion formation test were used to
design the exposure in the genotoxicity assays
in vitro. Comparable assays are classically con-
ducted to test medical devices that contain toxico-
logically relevant metals like nickel (Wever et al.,
1997; Tomakidi et al., 1999; Montanaro et al.,
2005). The procedures have been developed by US
Pharmacopoeia, have been adapted and laid down
inISO10993andgenotoxicityassaysconductedwith
extracts are integral part of the safety assessment of
medical devices since the mid-1990s. Comparable
designs have also been used to investigate cadmium-
containing dusts sampled under occupational condi-
tions (Cavallo et al.,2 0 0 8 ) but have up to the author’s
knowledge not been systematically conducted on
nickel (Zhao et al.,2 0 0 9 ) or other pure metals.
Genotoxicity was addressed by a bacterial gene
mutation assay, a mammalian gene mutation and
a chromosome aberration assay, and DNA damage
by an unscheduled DNA synthesis (UDS) assay. In
addition, cell-transforming potential was investi-
gated by a Syrian hamster embryo (SHE) cell trans-
formation assay. Effects on DNA repair were
investigated in a modiﬁed UDS assay (DNA was
damaged to increasing extents by incubation with a
knownDNA-damagingagent,2-acetylaminoﬂuorene,
and the effect of simultaneous co-incubation with
beryllium metal extracts on DNA repair was
investigated).
All tests were conducted with extracts of the metal
powder generated by extraction of the metal powder
under simulated lung conditions (37C under non-
abrasive shaking for 72 h) and the undissolved
particles were removed before incubation by centri-
fugation. This procedure was applied for three rea-
sons: (i) testing of soluble compounds instead of
the metal is considered an oversimpliﬁcation ignor-
ing toxicokinetics and thus not adequate for assess-
ment of the metal, (ii) particles were removed, as
the presence of particulatematter can complicate mi-
croscopic evaluation, and (iii) the cells validated for
use in the assays are not primary cells adapted to
contact with particulate matter, which might trigger
secondary effects (experimental artifacts) in the
test cells. The extraction conditions were designed
to achieve the highest technically possible concen-
tration of beryllium ions while maintaining the
integrity of the cell culture media.
Since the grouping approach is considered as not
adequate for beryllium and its compounds and no re-
liable data on acute toxicity, local effects, and muta-
genicityofberylliummetalhaveeverbeengenerated,
beryllium metal powder was tested according to the
respective OECD guidelines for acute oral toxicity,
potential skin and eye irritation/corrosion properties,
and skin sensitization potential.
The scope of this publication is to present new test
data generated on beryllium metal. Interpretation
and implementation into the scientiﬁc and regulatory
Beryllium Metal I. - Experimental Results 31context of existing studies are done in a separate ar-
ticle published in the same issue of this journal
(Strupp, 2010).
MATERIALS AND METHODS
All investigations were performed under good
laboratory practice at Harlan Laboratories Ltd,
Switzerland/Germany. The laboratory is Association
for Assessment and Accreditation of Laboratory
Animal Care accredited, and all vertebrate studies
were conducted under permit of the Kantonales
Veterina ¨ramt Basel Land, Switzerland. Full study
reports are archived under the study numbers
B52108, B52132, C15743, C02024, C31245,
C31267, C64286, C24888, C24890, and C24901.
Rats and rabbits were obtained from Harlan Labora-
tories B.V., Horst, the Netherlands; guinea pigs and
Syrian golden hamsters were obtained from Charles
River, Kissleg, Germany. All animals were allowed
to acclimatize to laboratory conditions for at least
5 days before start of treatment and were housed in
groups of three (rats)/individually (guinea pigs)
in Macrolon type 4 cages on softwood bedding or
individually in stainless steel cages (rabbits).
Beryllium metal powder (Batch O-30H) was ob-
tained from Brush Wellman Inc., OH, USA, and
the same batch was used in all tests. The metal pow-
der had a purity of 99.4% beryllium with small im-
purities from beryllium oxide (0.4%) and traces
(,0.05%) of other metals. The particles were all
,44 lm diameter, with  90% by weight between
10 and 44 lm and with a substantial number of par-
ticles ,10 lm (10%) and ,4.5 lm (1.5%). Thus,
a signiﬁcant number of particles were small enough
to theoretically reach the alveoli. Beryllium chloride
(Lot 05987AH, purity 99%) and all other chemicals
used, if not indicated otherwise, were obtained from
Sigma-Aldrich, Buchs, Switzerland. Artiﬁcial lung
ﬂuid of pH 7.4 (Gamble’s solution) was prepared
at Harlan and consisted of 6.6 g l
 1 NaCl, 2.7 g l
 1
NaHCO3, 0.0022 g l
 1 CaCl2 2H 2O, 0.3580 g l
 1
Na2HPO4, 0.08 g l
 1 Na2SO4, 0.21 g l
 1 MgCl2,
0.118 g l
 1 glycine, 0.153 g l
 1 sodium citrate,
0.18 g l
 1
L-sodium tartrate, 2 g l
 1 formalde-
hyde, 0.171 g l
 1 pyruvic acid sodium salt, and
0.175 g l
 1
L-lactic acid sodium salt dissolved in wa-
ter, pH adjusted to 7.4. The artiﬁcial lung ﬂuid of pH
4.5(artiﬁciallysosomalﬂuid)waspreparedatHarlan
and consisted of 3.21 g l
 1 NaCl, 6.0 g l
 1 NaOH,
20.8 g l
 1 citric acid, 0.097 g l
 1 CaCl2, 0.179 g l
 1
Na3PO4 7H 2O, 0.039 g l
 1 Na2SO4, 0.106 g
l
 1 MgCl2 6H 2O, 0.059 g l
 1 glycerol, 0.077 g l
 1
sodium citrate dihydrate, 0.09 g l
 1 sodium tartrate
dihydrate, 0.085 g l
 1
L-lactic acid sodium salt,
0.086 g l
 1 sodium pyruvate, 1 ml l
 1 formaldehyde,
pH adjusted to 4.5. Culture media and cell culture
supplements were from Life Technologies, Eggen-
stein, Germany, and PAA Laboratories, Co ¨lbe,
Germany. Although it is recognized that metabolism
of beryllium metal by the metabolic activation
system (rat liver S9 mix) is unlikely, it was included
in the genotoxicity tests to meet the regulatory
requirements.
Acute oral toxicity was tested according to OECD
guideline 423. Brieﬂy, two groups of each three
female RccHan:WIST (SPF) rats (10 weeks and
174–195 g at dosing) were fasted overnight and
exposed to a single dose of 2000 mg kg
 1 body
weight (b.w.) beryllium metal powder formulated
in polyethylene glycol 300 at a dosing volume of
10 ml kg
 1 b.w. by oral gavage. The animals were
housed in groups of three with ad libitum access to
pelleted standard rodent diet (except for the fasting
as described above) and tap water and observed for
mortality, viability, clinical signs, and body weight
development for 14 days. At the end of the observa-
tion period, all animals were sacriﬁced and subjected
to a detailed macroscopic necropsy.
Skin irritation/corrosion was tested according to
OECD guideline 404. Brieﬂy, 0.5 g of beryllium
metal powder (moistened with  0.5 ml of water to
intensify skincontact) wasapplied to theshorn intact
skin (2.5   2.5 cm) of each of three New Zealand
White (SPF) rabbits (one male: 17 weeks and 2.4
kg, two females: 16 weeks and 2.1 and 2.4 kg at dos-
ing) and held in place for 4 h under semi-occlusive
conditions (surgical gauze patch held in contact with
the skin by means of an adhesive hypoallergenic
semi-occlusive dressing and a restrainer bandage
wrapped around the abdomen). The test item was
removed by washing with lukewarm water after
exposure. The animals were housed individually
with ad libitum access to standard pelleted rabbit
diet and tap water. The application site was observed
for signs of skin irritation 1, 24, 48, and 72 h after
removal of the test substance, and skin reactions
were graded according to the scoring system
provided in Commission Regulation (EC) 440/
2008 B.4.
Eye irritation was tested according to OECD
guideline 405. As no signs of irritation were ob-
served in the skin irritation study, the same animals
were used in the eye irritation study to reduce the
use of vertebrates. Brieﬂy, 0.1 g beryllium metal
powder was instilled into the conjunctival sac of
the left eye of each of the three rabbits. The untreated
eye served as control. The eyelids were held together
32 C. Struppfor 1 s to prevent loss of test item. The treated eye
was not rinsed before evaluation at 1, 24, 48, 72 h,
and 7 days after administration. The animals were
housed individually with ad libitum access to stan-
dard pelleted rabbit diet and tap water. Observed
signs of irritation were graded according to the scor-
ingsystem provided in Commission Regulation (EC)
440/2008 B.5.
Skin sensitization was tested according to OECD
guideline 406. The local lymph node assay in mice
was considered as an alternative, but as beryllium
metal cannot be dissolved in a vehicle suitable for
this assay to grant systemic exposure and suitability
of the assay for metals is limited, the maximization
method developed by Magnussen and Kligman was
applied. Brieﬂy, 10 male Dunkin-Hartley guinea
pigs (5–6 weeks and 344–383 g) were treated by
intradermal administration of a beryllium metal
powder suspension together with Freund’s complete
adjuvant into the shorn dorsal skin of the scapular
region [three pairs of injections, (i) 1:1 (v/v) mixture
of Freund’s complete adjuvant and physiological
saline, (ii) the test item at 15% in polyethylene gly-
col 300, and (iii) the test item at 15% in a 1:1 (v/v)
mixture of Freund’s complete adjuvant and physio-
logical saline]. The 15% suspension was the highest
concentration that could technically pass the needle
for intradermal injection, while higher concentra-
tions in a pretest did not pass. One week thereafter,
this application was followed by an epidermal
application on the same site (50% in polyethylene
glycol 300, occluded conditions, 48 h) to induce sen-
sitivity. The concentration used was the lowest
concentration triggering a slight dermal irritation re-
sponse in a pretest. Two weeks later, allergic contact
reactions were challenged by epidermal application
to the skin (10% in polyethylene glycol, occluded,
48 h) of the left ﬂank. The concentration used was
the highest non-irritating dose in a pretest. A control
group of ﬁve male guinea pigs was treated in the
same way as the test group, but beryllium was
replaced by the respective volume of the vehicle
polyethylene glycol. The animals were housed indi-
vidually with ad libitum access to standard pelleted
guinea pig diet and tap water. Skin at the application
sitewas depilated by a commercial product (VEET
cream, Reckitt & Colman AG, Switzerland)  3h
before assessment of skin reactions, ﬂushed with
warm water, and blotted dry. Reactions (erythema
and edema) were evaluated 24 and 48 h after
challenge exposure for local reactions and were
graded(05 novisiblechange,1 5discreteorpatchy
erythema,2 5 moderateandconﬂuenterythema,and
3 5 intense erythema and swelling). Animals with
a visible reaction (grades 1–3) were considered as
positive responders. Correct functionality of the test
system in the laboratory was investigated in a posi-
tive control study with 3% alpha-cinnamaldehyde
(formulated in polyethylene glycol 300) 1 month be-
fore the study on beryllium metal.
Ion formation from the beryllium metal particles
under simulated lung conditions was tested cell free.
Beryllium metal and beryllium chloride were loaded
at 100 mg l
 1 [worst-case loading rate proposed in
OECD guidance No. 29 (OECD, 2001)] in Gamble’s
solution (pH 7.4, simulating normal lung conditions)
or artiﬁcial lysosomal ﬂuid (pH 4.5, simulating
lysosomal environment and worst-case assumption),
respectively, and shaken under non-abrasive
conditions at 37C in the dark. Triplicate bottles
were incubated for each sampling time point and
the pH of the solutions was controlled on days 1,
2, and 3 and later on a weekly basis. The pH was
found to be constant with a maximum deviation
of –0.4 pH units and was adjusted if the deviation
was .0.1 pH units. Samples were analyzed after 1,
7, 14, and 28 days. Prior to analysis, particulate
beryllium metal was removed by centrifugation
(3000 x g, 25 min) and the supernatant acidiﬁed with
nitric acid to prevent precipitation during analysis
time. Samples were analyzed by atomic absorption
spectrometry (k 5 234.9 nm) after calibration
with beryllium chloride standard (J.T. Baker,
Phillipsburg, NJ, USA). Results were expressed as
percent dissolved of theoretically available for disso-
lution to allow comparison, as the recommended
loading rate is ﬁxed. The mass of beryllium con-
tained in the loaded 100 mg beryllium chloride
( 11.2 mg) was set to 100%, while for the pure
metal, the theoretically dissolvable beryllium was
100 mg l
 1.
Metal extract for exposure in the genotoxicity
assays was prepared by extraction of 100 mg l
 1 be-
ryllium metal powder in either 0.9% aqueous NaCl
(bacterial gene mutation) or the culture medium
for the respective cell system (mammalian cell chro-
mosome aberration/mammalian cell gene mutation/
UDS/cell transformation) by non-abrasive shaking
in the dark at 37C for 72 h. This protocol was devel-
oped based on the results of the ion formation test
and reﬂects a compromise between the maximum
achievable dissolution and sterility/quality (integrity
of supplements, vitamins, etc.) of the culture media
used in the genotoxicity assays. Particulate matter
was removed by centrifugation (3500 x g, 25 min)
and dissolved beryllium was determined by atomic
absorption spectrometry in the supernatant. The con-
centration of dissolved beryllium in the supernatant
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test.
Bacterial gene mutation (Ames test) was tested ac-
cording to OECD guideline 471. Brieﬂy, the beryl-
lium metal extract was used to expose the bacteria
(Salmonella typhimurium strains TA 1535, TA
1537, TA 98, and TA 100, and Escherichiacoli strain
WP2 uvrA) in the presence and absence of rat liver
S9 mix (Ames et al., 1975) to different dilutions of
extracts ranging from pure (100%) extract to 10%
in physiological saline. Three plates per strain and
dose were used in each of the two independent ex-
periments. The ﬁrst experiment was performed as
a plate incorporation assay and the repeat as pre-
incubation assay (60 min at 37C). Selection of
reverse mutants was performed by incubation for
48 h at 37C on commercially available selection
agar plates (E. Merck, Darmstadt, Germany) suitable
for the respective strain. Colonies were automati-
cally counted (Petri Viewer Mk2/Ames Study
Manager, Perceptive Instruments, Suffolk, UK).
Performance of the test system was checked by par-
allel testing of NaN3, 4-nitro-o-phenylene-diamine,
methyl methane sulfonate without metabolic
activation, and 2-aminoanthracene with metabolic
activation.
Mammalian cell gene mutation at the hypoxanthine-
guanine phosphoribosyltransferase locus (HPRT
test) was tested according to OECD guideline 476.
Brieﬂy, the beryllium metal extract was used to ex-
pose the cells (V79 Chinese hamster lung ﬁbro-
blasts) in the presence and absence of rat liver S9
mix (Ames et al., 1975) to different dilutions of ex-
tracts ranging from pure (100%) extract to 12.5% in
culture medium (minimum essential medium, sup-
plemented with 10% fetalcalf serum and 1% neomy-
cin sulfate). Two independent cultures were exposed
per dose level in each of the two independent experi-
ments. Before use, each batch of cells was checked
for karyotype stability, mycoplasma contamination,
and spontaneous mutant frequency. Cells were ex-
posed for 4 h in the presence or absence of metabolic
activation (serum free) and in the second experiment
for 24 h in absence of S9 mix (with serum) and for 4
h in the presence of metabolic activation (serum
free). After exposure, cells werewashed and allowed
to express their phenotype for 6 days under normal
maintenance conditions (4.5% CO2,3 7 C, sub-
culturing; relative cloning efﬁciency as a marker of
cytotoxicity was determined in parallel). 6-Thiogua-
ninewas added to the medium (11 lgm l
 1) for 7–10
days, eliminating non-mutated cells by its cytotoxic
activity. Colonies formed from surviving cells were
stained with methylene blue and counted. Perfor-
mance of the test system was checked by parallel
testing of ethylmethane sulfonate (Acros Organics,
Geel, Belgium) without metabolic activation and
7,12-dimethylbenz(a)anthracene with metabolic
activation.
Mammalian cell chromosome aberration was
tested according to OECD guideline 473. Brieﬂy,
the beryllium metal extract was used to expose the
cells (whole-blood cultures obtained from two
healthy female donors, 31 and 35 years of age) in
the presence and absence of rat liver S9 mix (Ames
et al., 1975) to different dilutions of extracts ranging
from pure (100%) extract to 50% in culture medium
[Dulbecco’s modiﬁed eagle medium/Ham’s F12 me-
dium; mixture 1:1, supplemented with 10% fetal calf
serum, 100 U ml
 1 penicillin, 100 lgm l
 1 strepto-
mycin, 3 lgm l
 1 phytohemagglutinin, 25 000 USP
Um l
 1 heparin, and 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid]. Two independent
cultures were exposed per dose level in each of the
two independent experiments. Cells were main-
tained at 4.5% CO2,3 7 C. Cells were exposed for
4 h in the presence of metabolic activation (serum
free) and in absence of metabolic activation (with se-
rum). In the second experiment, cells were incubated
for 4 h in the presence (serum free) and for 22 h in
absence (with serum) of metabolic activation. Divid-
ing cells were arrested in metaphase by addition of
0.2 lgm l
 1 colcemid (Fluka, Neu-Ulm, Germany),
and erythrocytes were removed by incubation in hy-
potonic solution (0.0375 M KCl) with subsequent
centrifugation. Cells (human peripheral blood lym-
phocytes) were ﬁxed with methanol/glacial acetic
acid, stained on microscope slides with Giemsa solu-
tion, and microscopically evaluated (at least 100
well-spread metaphases/cell culture). Performance
of the test system was checked by parallel testing
of ethylmethane sulfonate (Acros Organics) without
metabolic activation and cyclophosphamide with
metabolic activation.
Inﬂuence of beryllium on UDS was tested accord-
ing to OECD guideline 483. Brieﬂy, hepatocytes
were isolated by in situ collagenase perfusion of
the liver (0.05% collagenase in Hank’s balanced salt
solution, 37C) in anesthetized rats. Livers were
excised, minced, and cells isolated by ﬁltering
through a stainless steel mesh. Cell viability was de-
termined by trypan blue exclusion, and cells were
seeded in six-well plates (5   10
5 viable cells per
well) containing a gelatinized round cover slip.
Culture conditions were 5% CO2, humidiﬁed,
37C, in William’s medium E supplemented with
2.38 mg ml
 1 4-(2-hydroxyethyl)-1-piperazinee-
thanesulfonic acid, 0.29 mg ml
 1
L-glutamine,
34 C. Strupp100 U ml
 1 penicillin, 0.10 mg ml
 1 streptomy-
cin, 0.50 lgm l
 1 insulin, and 10% fetal calf se-
rum. Non-attached cells were removed after 1.5
h by washing, and adherent cells were exposed
to the extracts of beryllium metal containing triti-
ated thymidine (5 lCi ml
 1, speciﬁc activity 20 Ci
mmol
 1; New England Nuclear, D-63033
Dreieich) in culture medium. Beryllium metal ex-
tracts were applied at 50 and 100%. After an ex-
posure of 18 h, cells were washed, nuclei
allowed to swell in a hypotonic solution of 1% so-
dium citrate for 10 min, cells ﬁxed by three
changes of methanol:acetic acid (3:1), rinsed with
ethanol, and air-dried. The cover slips were coated
with photographic emulsion (KODAK NTB2, Tec-
nomara, Fernwald, Germany) in the dark, exposed
for 7 days at 4C, developed (KODAK DEKTOL)
at room temperature, ﬁxed (TETENAL, Tetenal,
Norderstedt, Germany), and stained with hematox-
ylin/eosin. The number of silver grains above the
nucleus and the number of grains of one nu-
clear-sized cytoplasm area adjacent to the nucleus
were counted automatically (Scorecerer UDS de-
vice version 2.0 DT3152, Perceptive Instruments)
under a NIKON microscope. At least two slides
per concentration and 50 cells per slide were eval-
uated, excluding labeled S-phase cells. Perfor-
mance of the test system was checked by
parallel testing of 2-acetylaminoﬂuorene.
In addition to this standard assay, a modiﬁcation
was introduced to address apotential inﬂuence of be-
ryllium metal extracts on repair of an existing DNA
damage. To this end, increasing concentrations of 2-
acetylaminoﬂuorene were used to damage the DNA
in the hepatocytes in a dose-dependent manner. Cells
were co-incubated with beryllium metal extracts,
and DNA synthesis was determined at the end of
treatment as described above.
Cell transformation (SHE assay) was tested
according to Commission Regulation (EC) No.440/
2008 B.21. Brieﬂy, SHE cells were isolated from
Syrian golden hamster [LAK:LVG (SYR)] embryos
at day 13 post coitum. Embryonic tissue (after de-
capitation, evisceration, and delimbing) was minced
and blood removed from the tissue by several re-
suspension steps in ice-cold wash buffer (Hank’s
balanced salt solution calcium/magnesium free,
200 U ml
 1 penicillin, and 200 lgm l
 1 strepto-
mycin). The tissue was stirred three times for
10 min at room temperature in dissociation solution
(wash buffer supplemented with 0.125% trypsin and
0.0625% pancreatin) and supernatant containing the
SHE cells was collected after each interval. Cells
were plated in culture dishes and allowed to grow
(10% CO2 at 37C) antibiotic free until60–80% con-
ﬂuent, detached by trypsinization, and stored frozen
until use. Before use, each batch was checked for
plating efﬁciency, mycoplasma contamination, and
spontaneous transformation. To increase plating
efﬁciency, culture dishes were pre-seeded with
lethally irradiated cells (‘feeder cells’). The beryl-
lium metal extract was used to expose the SHE cells
to different dilutions of extracts ranging from pure
extract (100%) to 25% of extract in culture medium
(Dulbecco’s modiﬁed eagle medium—LeBoeuf’s
modiﬁcation, supplemented with 20% fetal calf
serum and 4 mM L-glutamine). Exposure was in
one experimental set-up for 24 h with additional
substance-free culturing period of 6 days and in
a second set-up for 7 days continuously. Five to ten
culture dishes were used per exposure condition in
each of the two independent experiments. After
exposure, cells were ﬁxed with methanol, stained
with Giemsa solution, washed with water, and
allowed to air-dry before microscopic evaluation.
For each test group, .1000 colonies were evaluated
for morphological transformation. Performance of
the test system was checked by parallel testing of
benzo[a]pyrene.
RESULTS
Acute oral toxicity study in rats
All animals survived until scheduled necropsy. All
animals gained weight in the range expected for rats
of this sex, strain, and age. No clinical signs of tox-
icity were observed; the only observation made was
gray staining of the feces on the day after administra-
tion (likely to be caused by presence of unchanged
test item). No ﬁndings indicative of toxicity were
identiﬁed at macroscopic necropsy (Table 1).
Skin irritation/corrosion
No signs of skin irritation or corrosion were ob-
served at any of the observation time points. No mor-
tality, signs of toxicity, or effects on body weight
development were observed throughout the study
period (Table 2).
Eye irritation/corrosion
One hour after instillation of beryllium metal
powder, slight chemosis and slight to moderate
redness of the conjunctiva were observed in all
animals.Atthenextobservationtimepoint,24h,only
slight redness was observed, which persisted in all
animals for at least 72 h. At the fourth observation
time point, 7 days, no signs of eye irritation were
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signs of toxicity, or effects on body weight develop-
ment were observed throughout the study period
(Table 3).
Skin sensitization
None of the observed animals demonstrated any
skin reaction after challenge procedure (Table 4).
Correct functionality of the test system was demon-
strated in a positive control study conducted in the
same laboratory 1 month before this study on beryl-
lium metal. No mortality, signs of toxicity, or effects
on body weight development were observed
throughout the study period.
Ion formation
The maximum solubility of beryllium ions at
neutral pH is obviously limited due to reaching the
solubility equilibrium, as a maximum of  7% of
the available beryllium of the soluble BeCl2 dis-
solved, while at lower pH (4.5) BeCl2 dissolved al-
most completely at the same loading rate. The
solubility of beryllium metal differed signiﬁcantly
from the solubility of beryllium chloride, especially
under conditions of neutral pH. The percentage of
beryllium ions dissolved from metal was found to
be factor 3–40 lower than from beryllium chloride
(Table 5).
Dissolution kinetics of beryllium metal and beryl-
lium chloride were found to be too different to con-
duct the invitro tests with beryllium chloride [a more
detailed discussion can be found in the same issue of
this journal (Strupp, 2010)]. Consequently, the tests
were conducted with extracts of the metal as
described under Materials and Methods.
Bacterial gene mutation
The Ames test conducted with beryllium metal
extracts was negative with and without metabolic
activationinbothindependentexperiments(Table6).
Mammalian cell gene mutation
No mutagenic potential was observed with beryl-
lium metal extracts, neither in the presence nor in
the absence of metabolic activation (Table 7).
Chromosome aberration in mammalian cells
The chromosome aberration assay with extracts of
beryllium metal conducted with human primary
lymphocytes to address cytogenicity did not reveal
a genotoxic potential, neither in the presence nor in
the absence of metabolic activation (Table 8). The
single signiﬁcant increase in the number of aberrant
cells (excluding gaps) upon long-term treatment in
absence of metabolic activation is considered not
Table 1. Acute oral toxicity study in rats
Rat
no.
Dose
(mg kg
 1
b.w.)
Mortality
(days 1–15)
Observations Weight gain
(g) (days 1–8/
days 8–15)
1 2000 0/3 Feces stained
gray on day 2
22.9/21.5
2 Feces stained
gray on day 2
17.7/11.1
3 Feces stained
gray on day 2
15.8/9.4
4 2000 0/3 Feces stained
gray on day 2
25.5/12
5 Feces stained
gray on day 2
14.8/13.4
6 Feces stained
gray on day 2
23.3/9.8
Table 2. Skin irritation study in rabbits
Rabbit no. Erythema (grades 0–4) Edema (grades 0–4)
04 05 06 04 05 06
After 1 h 0 0 0 0 0 0
After 24 h 0 0 0 0 0 0
After 48 h 0 0 0 0 0 0
After 72 h 0 0 0 0 0 0
Table 3. Eye irritation study in rabbits
Rabbit no. Cornea
(grades 0–4)
Iris
(grades 0–2)
Conjunctiva
Redness (grades 0–3) Chemosis (grades 0–4)
04 05 06 04 05 06 04 05 06 04 05 06
After 1 h 0 0 0 0 0 0 2 1 2 1 1 1
After 24 h 0 0 0 0 0 0 1 1 1 0 0 0
After 48 h 0 0 0 0 0 0 1 1 1 0 0 0
After 72 h 0 0 0 0 0 0 1 1 1 0 0 0
24–72 h mean 0 0 0 0 0 0 1 1 1 0 0 0
After 7 days 0 0 0 0 0 0 0 0 0 0 0 0
36 C. StruppTable 4. Skin sensitization study in guinea pigs
Number of animals with skin reactions (no. of animals
with skin reactions/total no. of animals in group)
Time point for scoring (after removal of challenge patch) Vehicle control Test item group
Study with beryllium metal
24 h 0/5 0/10
48 h 0/5 0/10
Positive control study with alpha-hexylcinnamaldehyde
24 h 0/5 10/10
48 h 0/5 10/10
Table 5. Ion formation test from beryllium metal and beryllium chloride: percent dissolved beryllium of theoretically available
for dissolution (–standard deviation)
Extraction period (days) 1 7 14 28
Gamble’s solution (pH 7.4)
Beryllium metal 0.17 – 0.01 0.31 – 0.01 0.32 – 0.02 0.57 – 0.20
Beryllium chloride 7.01 – 0.70 6.29 – 0.50 3.24 – 0.30 4.48 – 0.70
Artiﬁcial lysosomal ﬂuid (pH 4.5)
Beryllium metal 1.01 – 0.04 10.60 – 0.40 18.90 – 0.60 32.60 – 1.40
Beryllium chloride 93.90 – 5.70 93.90 – 4.20 87.20 – 1.90 90.60 – 1.80
Table 6. Ames test with beryllium metal extracts: mean revertants per plate
Strain Salmonella typhimurium Escherichia coli
TA 1535 TA 1537 TA 98 TA 100 WP2 uvrA
Metabolic activation (S9)  þ  þ  þ  þ   þ
Experiment 1 (plate incubation method)
a
Beryllium metal extract (%) 0
b 15 19 12 11 26 30 125 140 58 60
10 18 19 12 12 25 27 134 148 62 68
20 16 17 11 11 28 34 115 132 59 65
40 13 17 10 13 26 31 122 145 57 58
60 15 18 6 12 31 33 132 141 67 61
80 15 15 10 11 34 30 130 142 57 62
100 16 14 10 12 33 32 125 125 61 62
Positive control
c 1998 373 83 258 352 1662 2125 2418 1492 181
Experiment II (pre-incubation method)
d
Beryllium metal extract (%) 0
b 15 21 17 19 22 31 156 14 52 53
10 11 19 14 19 24 34 159 12 55 64
20 13 22 15 14 22 38 157 12 58 56
40 14 15 16 17 25 36 150 10 53 61
60 14 19 15 17 21 31 161 11 47 55
80 13 20 12 18 19 31 163 16 53 63
100 17 19 19 18 20 34 142 13 53 64
Positive control
c 1840 237 105 184 377 1324 1906 1550 284 248
aAnalytical concentration in the 100% extract: 734 lg beryllium per liter 5 81 lmol l
 1.
bVehicle: 0.9% NaCl.
cWithoutmetabolic activation:TA 1535 and 100 5 sodiumazide, TA 1537 and 98 5 4-nitro-o-phenylene-diamine, WP2 uvrA 5
methyl methane sulfonate; with metabolic activation: 2-aminoanthracene in all strains.
dAnalytical concentration in the 100% extract: 124 lg Be per liter 5 14 lmol l 1.
Beryllium Metal I. - Experimental Results 37to be treatment related because there was no dose-
dependent trend (the effect was not observed at the
high dose), and no hints from the other parallel ex-
periments (with or without metabolic activation)
supported the relevance of this ﬁnding.
Unscheduled DNA synthesis
The beryllium metal extract did not induce DNA
repair synthesis in the UDS assay in rat primary
hepatocytes and is thus not considered to have
damaged the DNA. No cytotoxicity was observed
Table 7. Mammalian cell gene mutation (HPRT) assay in V79 cells with beryllium metal extracts
Exposure
period
Expression
time/selection
time
Beryllium
metal extract
(%)
Culture I Culture II
Relative
cloning
efﬁciency (%
control)
Mutant
colonies per
10
6 cells
Relative
cloning
efﬁciency (%
control)
Mutant
colonies per
10
6 cells
Without S9 mix
4h
a 6 days/
7–10 days
0
b 100.0 22.9 100.0 17.4
12.5 98.4 18.7 102.6 22.0
25 102.3 11.8 98.3 16.3
50 93.8 7.4 102.9 9.1
75 99.6 21.9 103.7 23.4
100 93.5 19.7 96.5 20.7
Positive
control
c 51.4 125.9
d 53.2 124.8
d
24 h
e 6 days/
7–10 days
0
b 100.0 11.0 100.0 9.3
12.5 93.3 9.6 113.6 16.6
25 89.9 6.5 86.8 11.8
50 89.3 9.8 86.3 18.6
75 83.1 10.2 78.2 10.7
100 90.8 12.1 86.8 12.3
Positive
control
c 86.0 277.3
d 73.3 261.3
d
With S9 mix
4h
a 6 days/
7–10 days
0
b 100.0 31.0 100.0 7.0
12.5 99.0 32.4 102.2 21.6
25 105.2 12.0 101.8 19.0
50 98.9 16.2 101.4 5.3
75 102.5 17.3 99.6 22.7
100 99.2 16.8 99.0 13.3
Positive
control
c 63.6 2532.0
d 54.7 554.3
d
4h
a 6 days/
7–10 days
0
b 100.0 21.1 100.0 24.1
12.5 91.0 48.2 95.5 8.5
25 97.7 10.3 94.1 12.3
50 93.0 9.1 97.4 12.1
75 96.3 29.6 91.0 13.6
100 89.0 10.2 87.8 8.3
Positive
control
c 56.1 1142.9
d 56.5 1171.9
d
aAnalytical concentration in the 100% extract: 4 lg beryllium per liter 5 0.4 lmol l
 1.
bExtraction medium.
cWithout metabolic activation: ethylmethane sulfonate (150 lgm l
 1 for 4-h incubation, 1.1 lgm l
 1 for 24-h incubation); with
metabolic activation: 7,12-dimethylbenz(a)anthracene (1.1 lgm l
 1).
dMutation frequency statistically signiﬁcant higher than corresponding control values (linear regression, least squares).
eAnalytical concentration in the 100% extract: 14 lg Be per liter 5 1.6 lmol l
 1.
38 C. Struppas determined in parallel by neutral red uptake
(Table 9).
Withinthesameexperiment,increasingconcentra-
tions of the positive control, 2-acetylaminoﬂuorene,
were applied to parallel cultures and co-incubated
with beryllium metal extracts. While no effects of
beryllium metal extracts on DNA (repair) synthesis
were observed under conditions where 0–50%
cells were in repair synthesis (5damaged by the
2-acetylaminoﬂuorenetreatment),atthehighestcon-
centration (2.23 lgm l
 1 2-acetylaminoﬂuorene,
96% cells in repair synthesis), an effect on DNA
repair synthesis was observed (Table 10).
To verify the observed response, the upper dose
range of 2-acetylaminoﬂuorene was investigated by
closer dose spacing. DNA damage in the repeat
experiment was high in all concentrations of 2-
acetylaminoﬂuorene applied (70–96% cells in repair
synthesis), but no cytotoxicity was observed as
determined in parallel by neutral red uptake (data
not shown in detail; neutral red uptake was in all
conditions applied between 99 and 113% of the
Table 8. Chromosome aberration assay in human lymphocytes with beryllium metal extracts
Exposure period Preparation
interval
Beryllium metal
extract (%)
Mitotic index (%
control)
Aberrant cells (%)
Inclusive gaps
a Exclusive gaps
a With exchanges
Without S9 mix
4h
b 22 h 0
c 100.0 1.0 0.5 0.0
50 86.9 0.5 0.5 0.0
75 101.6 3.0 2.5 0.0
100 72.9 1.0 1.0 0.0
Positive control
d 77.3 10.5 9.5
e 3.0
22
f 22 h 0
c 100.0 0.5 0.5 0.0
50 73.3 0.0 0.0 0.0
75 84.0 3.5 3.0
e 0.0
100 78.7 2.0 1.5 0.0
Positive control
d 33.2 19.5 18.5
e 3.5
With S9 mix
4h
b 22 h 0
c 100.0 4.0 2.5 0.0
50 76.0 0.5 0.5 0.0
75 86.2 2.5 2.0 0.0
100 79.3 0.5 0.5 0.0
Positive control
d 37.5 10.0 10.0
e 0.0
4h
b 22 h 0
c 100.0 2.0 1.5 0.5
50 90.9 2.0 2.0 0.0
75 86.9 1.5 1.0 0.0
100 108.8 1.5 1.5 0.5
Positive control
d 38.0 17.0 16.5
e 1.5
aInclusive cells carrying exchanges.
bAnalytical concentration in the 100% extract: 21 lg beryllium per liter 5 2.3 lmol l
 1.
cExtraction medium.
dWithout metabolic activation: ethylmethane sulfonate (825 lgm l
 1 for 4-h incubation, 770 lgm l
 1 for 22-h incubation); with
metabolic activation: cyclophosphamide (15 lgm l
 1).
eAberration frequency statistically signiﬁcant higher than corresponding control values (Fisher’s exact test).
fAnalytical concentration in the 100% extract: 4 lg Be per liter 5 0.4 lmol l
 1.
Table 9. UDS assay in rat primary hepatocytes with
beryllium metal extracts
Beryllium metal
extract (%)
Cells in repair (%) Mean net grain counts
0
a 6  1.7
50 7  3.63
100
b 2  4.81
Positive control
c 96 29.93
aExtraction medium.
bAnalytical concentration in the 100% extract: 61 lg
beryllium per liter 5 6.8 lmol l
 1 (not determined in the
main experiment, but in a range-ﬁnding experiment).
c2-Acetylaminoﬂuorene (2.23 lgm l
 1).
Beryllium Metal I. - Experimental Results 39untreated control group). The trend to reduced DNA
repair was veriﬁed in the repeat experiment. The ab-
sence of a direct effect of beryllium metal extracts
onDNA repairsynthesis (5absenceofDNA damage)
without prior intentionalDNA damagewas conﬁrmed
in the repeat experiment as well (Table 11).
Cell transformation
All concentrations of beryllium metal extract
tested in the SHE cell assay had increased transfor-
mation rates compared to control (Table 12, Fig. 1).
SUMMARY
An overview of the acute, local, and genotoxicity
testing results is presented below: Beryllium metal
was found to have no relevant acute oral toxicity
and low local irritation properties and was found
not to be a skin sensitizer in animal studies con-
ducted in accord with internationally accepted test-
ing guidelines (Table 13). Solubility of beryllium
in artiﬁcial lung ﬂuids is dependent on the pH and
time of extraction and the solubility kinetics and
characteristics of beryllium metal differs largely
from the features of soluble beryllium chloride under
simulated lung conditions. The conducted in vitro
genotoxicity tests have limitations as they are not
ideal for investigating genotoxicity of poorly water
soluble test material and relatively artiﬁcial proce-
dures have to be applied to simulate the in vivo situ-
ation but can give a good impression on relevance of
the individual endpoints for the in vivo situation. A
set of genotoxicity tests in vitro, covering gene mu-
tation, chromosome aberration, and UDS (repair),
did not reveal any primary genotoxic potential for
beryllium metal when extracted under simulated
Table 11. Modiﬁed UDS assay in rat primary hepatocytes
with beryllium metal extracts: repeat experiment
Beryllium metal
extract (%)
2-Acetylaminoﬂuorene (lgm l
 1)
0 0.67 0.19 1.71 2.23
Cells in repair (%)
0
a 59 67 07 87 5
5 0 68 05 29 07 8
100
b 43 05 72 86 5
Mean net grain counts
0
a  5.13 31.62 9.02 11.14 18.14
50  7.42 12.26 6.8 14.37 12.18
100
b  6.91 2.22 5.34 1.95 7.06
aExtraction medium.
bAnalytical concentration in the 100% extract: 61 lg
beryllium per liter 5 6.8 lmol 1
 1 (not determined in the
main experiment, but in a range-ﬁnding experiment).
Table 10. Modiﬁed UDS assay in rat primary hepatocytes
with beryllium metal extracts
Beryllium metal
extract (%)
2-Acetylaminoﬂuorene (lgm l
 1)
0 0.018 0.06 0.2 0.67 2.23
Cells in repair (%)
0
a 61 11 41 5 4 8 9 6
5 0 71 21 92 2 4 5 3 5
100
b 2 7 15 11 48 60
Mean net grain counts
0
a  1.7  1.55  0.45  0.16 6.72 29.93
50  3.36  1.89  0.38 0.04 5.22 2.62
100
b  4.81  2.58  1.24  0.61 5.61 6.8
aExtraction medium.
bAnalytical concentration in the 100% extract: 61 lg
beryllium per liter 5 6.8 lmol 1
 1 (not determined in the
main experiment, but in a range-ﬁnding experiment).
Table 12. SHE cell transformation assay with beryllium metal extracts
Exposure period Beryllium metal extract (%) Relative plating efﬁciency
(% control)
Transformation frequency (%)
7 days
a 0
b 100.0 0.59
25 101.0 1.45
c
37.5 103.8 1.41
c
50 96.3 1.59
c
75 96.3 2.50
c
100 106.9 1.98
c
Solvent control
d 100.0 0.26
Positive control
e 93.3 3.12
c
aAnalytical concentration in the 100% extract: 22.95 lg beryllium per liter 5 2.5 lmol l
 1.
bExtraction medium
cTransformation frequency statistically signiﬁcant higher than corresponding control values.
dDimethylsulfoxide (0.2%); only relevant for positive control and not present in test item samples.
eBenzo[a]pyrene (5.0 lgm l
 1).
40 C. Strupplung conditions. An invitro cell transformation assay
with beryllium metal extracts did indicate a cell-
transforming potential of beryllium metal, and a
modiﬁed UDS test indicated a tendency for inhibi-
tion of DNA repair in pre-damaged cells. Beryllium
metal is obviously no classical mutagen and causes
no classical cytogenetic or DNA damage; an inter-
ference of the ions with DNA (repair) synthesis
Table 13. Overview on experimental results obtained with beryllium metal
Study Species or cell type Result
Acute oral toxicity Rat LD50 . 2000 mg kg
 1 b.w.
Skin irritation Rabbit No signs of skin irritation at
any time point.
Eye irritation Rabbit Slight initial conjunctival
redness, fully reversible
within 7 days. No effects on
cornea or iris.
Skin sensitization
(maximization method)
Guinea pig Not sensitizing.
Bacterial gene mutation
(Ames test)
Salmonella typhimurium/
Escherichia coli
Negative
Mammalian cell gene
mutation
V79 cell line (in vitro) Negative
Mammalian cell chromosome
aberration
Human lymphocytes (in vitro) Negative
Mammalian cell unscheduled
DNA repair synthesis (UDS
test)
Rat primary hepatocytes (in
vitro)
Negative (beryllium exposure
only); indication of reduced
repair of hepatocytes with
damaged DNA
Cell transformation (SHE
assay)
SHE cells (in vitro) Positive
Fig. 1. Typical microscopic pictures of a non-transformed and a transformed colony (outer rim to center) from this experiment are
given below.
Beryllium Metal I. - Experimental Results 41or genomic regulation is likely more relevant but
should be addressed by further investigations for
relevance in vivo.
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